Home › Companies › REGENXBIO Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and REGENXBIO Inc.’s Form 8-K, filed June 3, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 29, 2026: 7 items on REGENXBIO Inc.’s Form 8-K, filed June 3, 2026: 3 elected · 3 approved · 1 not approved.
Significant dissent: 1 director (31.9% against).
Notable dissent: 2 other board items (25.1%, 23.1% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore REGENXBIO Inc. in the interactive database Compare manager voting policies
These tallies are REGENXBIO Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jean Bennett, M.D., Ph.D. | 24,025,836 | -- | -- | 11,238,926 | 7,554,121 | 68% | Elected | — |
| Elect Director: A.N. "Jerry" Karabelas, Ph.D. | 27,124,923 | -- | -- | 8,139,839 | 7,554,121 | 77% | Elected | — |
| Elect Director: Daniel Tassé | 32,039,753 | -- | -- | 3,225,009 | 7,554,121 | 91% | Elected | — |
| 2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 | 42,526,553 | 244,785 | 47,545 | -- | 0 | 99.4% | Approved | — |
| 3. The compensation of the Company's named executive officers, as disclosed in the Proxy Statement | 32,392,302 | 2,722,825 | 149,635 | -- | 7,554,121 | 92% | Approved | — |
| 4. The Stock Option Exchange Program for the Company's non-executive employees | 26,352,456 | 8,853,230 | 59,076 | -- | 7,554,121 | 75% | Approved | — |
| 5. A Stock Option Exchange Program for the Company's executive employees | 14,097,815 | 21,021,531 | 145,416 | -- | 7,554,121 | 40% | Not approved | — |
Source: REGENXBIO Inc., Form 8-K, filed with the SEC on June 3, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
179 asset managers disclosed a vote on at least one REGENXBIO Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of REGENXBIO Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 7 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: A.N. "Jerry" Karabelas, Ph.D.
REGENXBIO Inc.’s own tally for this item (“Elect Director: A.N. "Jerry" Karabelas, Ph.D.”): 27,124,923 for, 8,139,839 withheld, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class II directors until the Company's 2029 annual meeting of stockholders:”
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 12,325,319 for, 417,873 withheld, 19,512 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,021,945 | 0 | 4,081 | 1,921 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 2,050,372 | 0 | 0 | 0 | For |
| State Street | 1,559,242 | 0 | 0 | 2,011 | For |
| Fidelity | 1,399,543 | 0 | 0 | 0 | For |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 342,335 | Withhold |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| Equitable | 67,490 | 0 | 0 | 46,030 | Mixed |
| MFS | 93,369 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,442 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 67,623 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,417 | 0 | 0 | 5,071 | Mixed |
| Brighthouse | 57,494 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 42,108 | 0 | 0 | 0 | For |
| Northern Trust | 30,712 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 29,212 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 26,809 | 0 | 0 | 0 | For |
| Voya | 25,779 | 0 | 0 | 0 | For |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: Daniel Tasse
REGENXBIO Inc.’s own tally for this item (“Elect Director: Daniel Tassé”): 32,039,753 for, 3,225,009 withheld, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class II directors until the Company's 2029 annual meeting of stockholders:”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 12,327,311 for, 415,893 withheld, 15,439 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,023,878 | 0 | 8 | 0 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 2,050,372 | 0 | 0 | 0 | For |
| State Street | 1,559,302 | 0 | 0 | 1,951 | For |
| Fidelity | 1,399,543 | 0 | 0 | 0 | For |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 342,335 | Withhold |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| Equitable | 67,490 | 0 | 0 | 46,030 | Mixed |
| MFS | 93,369 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,442 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 67,623 | 0 | 0 | 0 | For |
| Lincoln Financial | 58,417 | 0 | 0 | 5,071 | Mixed |
| Brighthouse | 57,494 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 42,108 | 0 | 0 | 0 | For |
| Northern Trust | 30,712 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 29,212 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 26,809 | 0 | 0 | 0 | For |
| Voya | 25,779 | 0 | 0 | 0 | For |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
68% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: Jean Bennett, M.D., Ph.D.
REGENXBIO Inc.’s own tally for this item (“Elect Director: Jean Bennett, M.D., Ph.D.”): 24,025,836 for, 11,238,926 withheld, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 : By the following vote, the following three persons were elected to serve as Class II directors until the Company's 2029 annual meeting of stockholders:”
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 11,726,819 for, 1,003,476 withheld, 32,410 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,996,858 | 0 | 4,089 | 27,000 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 2,050,372 | 0 | 0 | 0 | For |
| State Street | 1,557,594 | 0 | 0 | 3,659 | For |
| Fidelity | 1,372,143 | 0 | 0 | 27,400 | For |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 342,335 | Withhold |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 149,000 | Withhold |
| Equitable | 67,490 | 0 | 0 | 46,030 | Mixed |
| MFS | 0 | 0 | 0 | 93,369 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 79,442 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 67,623 | Withhold |
| Lincoln Financial | 58,417 | 0 | 0 | 5,071 | Mixed |
| Brighthouse | 47,885 | 0 | 0 | 9,609 | Mixed |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 42,108 | Withhold |
| Northern Trust | 0 | 0 | 0 | 30,712 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 29,212 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 26,809 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 25,779 | Withhold |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
46.3% of fund votes cast · no official result
The 59 asset managers below reported 5,916,446 for, 6,854,976 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,996,837 | 31,110 | 0 | 0 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 0 | 2,050,372 | 0 | 0 | Against |
| State Street | 1,198 | 1,560,055 | 0 | 0 | Against |
| Fidelity | 0 | 1,399,543 | 0 | 0 | Against |
| TIAA | 0 | 567,096 | 0 | 0 | Against |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 0 | 342,335 | 0 | 0 | Against |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 149,000 | 0 | 0 | Against |
| Equitable | 0 | 113,520 | 0 | 0 | Against |
| MFS | 0 | 93,369 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 79,442 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 67,623 | 0 | 0 | Against |
| Lincoln Financial | 26,317 | 37,171 | 0 | 0 | Mixed |
| Brighthouse | 47,885 | 9,609 | 0 | 0 | Mixed |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 0 | 42,108 | 0 | 0 | Against |
| Northern Trust | 0 | 30,712 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 29,212 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 0 | 26,809 | 0 | 0 | Against |
| Voya | 25,779 | 0 | 0 | 0 | For |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. All 59 are in the interactive database (link above).
75% Approved · of votes cast
Description as filed by funds: To approve a stock option exchange for our non-executive employees.
REGENXBIO Inc.’s own tally for this item (“4. The Stock Option Exchange Program for the Company's non-executive employees”): 26,352,456 for, 8,853,230 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4 : By the following vote, the stockholders approved, the Stock Option Exchange Program for the Company's non-executive employees:”
Support: 75% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 9,267,571 for, 3,495,133 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,996,864 | 31,082 | 0 | 0 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 2,050,372 | 0 | 0 | 0 | For |
| State Street | 1,198 | 1,560,055 | 0 | 0 | Against |
| Fidelity | 403,601 | 995,942 | 0 | 0 | Mixed |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 0 | 342,335 | 0 | 0 | Against |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 149,000 | 0 | 0 | Against |
| Equitable | 67,490 | 46,030 | 0 | 0 | Mixed |
| MFS | 93,369 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,442 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 67,623 | 0 | 0 | Against |
| Lincoln Financial | 26,317 | 37,171 | 0 | 0 | Mixed |
| Brighthouse | 47,885 | 9,609 | 0 | 0 | Mixed |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 0 | 42,108 | 0 | 0 | Against |
| Northern Trust | 0 | 30,712 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 29,212 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 26,809 | 0 | 0 | 0 | For |
| Voya | 25,779 | 0 | 0 | 0 | For |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
92% Approved · of votes cast
Prior year: 94.9% for (May 30, 2025 meeting) ▼ 2.6 pts
Description as filed by funds: Advisory vote on the compensation paid to the Company's executive employees.
REGENXBIO Inc.’s own tally for this item (“3. The compensation of the Company's named executive officers, as disclosed in the Proxy Statement”): 32,392,302 for, 2,722,825 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 : By the following vote, the stockholders approved, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,027,939 | 7 | 0 | 0 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 2,050,372 | 0 | 0 | 0 | For |
| State Street | 1,560,609 | 644 | 0 | 0 | For |
| Fidelity | 1,399,543 | 0 | 0 | 0 | For |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 342,335 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| Equitable | 113,520 | 0 | 0 | 0 | For |
| MFS | 93,369 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,442 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 67,623 | 0 | 0 | 0 | For |
| Lincoln Financial | 63,488 | 0 | 0 | 0 | For |
| Brighthouse | 57,494 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 42,108 | 0 | 0 | 0 | For |
| Northern Trust | 30,712 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 29,212 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 26,809 | 0 | 0 | 0 | For |
| Voya | 25,779 | 0 | 0 | 0 | For |
| SEI | 22,436 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 12,749,093 for, 2,113 against, 11,499 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Redmile Group, LLC | 4,368,804 | 0 | 0 | 0 | For |
| State Street | 2,434,900 | 3,368 | 0 | 0 | For |
| BlackRock | 2,321,870 | 11,543 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,137,498 | 0 | 0 | 0 | For |
| Invesco | 916,581 | 0 | 0 | 0 | For |
| AQR | 773,151 | 0 | 0 | 0 | For |
| Nuveen | 582,109 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 451,007 | 0 | 0 | 0 | For |
| Charles Schwab | 390,601 | 0 | 0 | 0 | For |
| Goldman Sachs | 382,655 | 0 | 0 | 0 | For |
| Vanguard | 334,594 | 0 | 0 | 0 | For |
| Integral Health Asset Management, LLC | 315,769 | 0 | 0 | 0 | For |
| Fidelity | 303,368 | 0 | 0 | 0 | For |
| Voss Capital, LP | 295,787 | 0 | 0 | 0 | For |
| ArchPoint Investors | 215,197 | 0 | 0 | 0 | For |
| Kintegral Advisory, LLC | 201,981 | 0 | 0 | 0 | For |
| Northern Trust | 189,428 | 1,455 | 0 | 0 | For |
| DE Shaw | 151,857 | 0 | 0 | 0 | For |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 149,000 | 0 | 0 | 0 | For |
| Two Sigma | 145,349 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 139,150 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 130,653 | 0 | 0 | 0 | For |
| Renaissance | 126,774 | 0 | 0 | 0 | For |
| JPMorgan | 106,652 | 0 | 0 | 0 | For |
| T. Rowe Price | 102,258 | 0 | 0 | 0 | For |
Institutional-manager reports, all 140 managers: 17,589,733 for, 181,017 against, 250 abstained. Showing the 25 largest; every one is in the interactive database (link above).
99.4% Approved · of votes cast
Prior year: 99.9% for (May 30, 2025 meeting) ▼ 0.5 pts
Description as filed by funds: To ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the year ending December 31, 2026.
REGENXBIO Inc.’s own tally for this item (“2. The appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 42,526,553 for, 244,785 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 : By the following vote, the stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 12,751,145 for, 59 against, 11,499 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,027,945 | 0 | 0 | 0 | For |
| JPMorgan | 2,052,743 | 0 | 0 | 0 | For |
| BlackRock | 2,050,372 | 0 | 0 | 0 | For |
| State Street | 1,561,194 | 59 | 0 | 0 | For |
| Fidelity | 1,399,543 | 0 | 0 | 0 | For |
| TIAA | 567,096 | 0 | 0 | 0 | For |
| Charles Schwab | 390,504 | 0 | 0 | 0 | For |
| Dimensional | 342,335 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 196,784 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 149,000 | 0 | 0 | 0 | For |
| Equitable | 113,520 | 0 | 0 | 0 | For |
| MFS | 93,369 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 79,442 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 67,623 | 0 | 0 | 0 | For |
| Lincoln Financial | 63,488 | 0 | 0 | 0 | For |
| Brighthouse | 57,494 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 48,492 | 0 | 0 | 0 | For |
| Global X | 44,443 | 0 | 0 | 0 | For |
| Russell Investments | 43,796 | 0 | 0 | 0 | For |
| ProShares | 42,108 | 0 | 0 | 0 | For |
| Northern Trust | 30,712 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 29,212 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 26,809 | 0 | 0 | 0 | For |
| Voya | 25,779 | 0 | 0 | 0 | For |
| SEI | 22,436 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 51,617,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 5.87% |
| 2 | JPMorgan | 3.98% |
| 3 | BlackRock | 3.97% |
| 4 | State Street | 3.02% |
| 5 | Fidelity | 2.71% |
| 6 | TIAA | 1.10% |
| 7 | Charles Schwab | 0.76% |
| 8 | Dimensional | 0.66% |
| 9 | Columbia Threadneedle | 0.38% |
| 10 | Delaware/Macquarie | 0.29% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Redmile Group, LLC | 8.46% |
| 2 | State Street | 4.72% |
| 3 | BlackRock | 4.52% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.20% |
| 5 | Invesco | 1.78% |
| 6 | AQR | 1.50% |
| 7 | Nuveen | 1.13% |
| 8 | STIFEL NICOLAUS & CO INC \MO\ | 0.87% |
| 9 | Charles Schwab | 0.76% |
| 10 | Goldman Sachs | 0.74% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 5,782,808 | 11.20% | Form 13F, quarter ended March 31, 2026 |
| Redmile Group, LLC | 5,198,830 | 10.07% | Proxy statement (DEF 14A), table as of April 1, 2026 |
| JPMorgan Chase | 3,483,800 | 6.75% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 3,374,140 | 6.54% | Form 13F, quarter ended March 31, 2026 |
| Entities Affiliated with Allan M. Fox Bryn Mawr Trust Company | 2,882,466 | 5.58% | Proxy statement (DEF 14A), table as of April 1, 2026 |
| State Street | 2,731,485 | 5.29% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 2,014,788 | 3.90% | Form 13F, quarter ended March 31, 2026 |
| Goldman Sachs | 1,839,463 | 3.56% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 1,137,498 | 2.20% | Form 13F, quarter ended March 31, 2026 |
| AQR Capital | 1,051,712 | 2.04% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 51,617,000 shares outstanding, as reported by REGENXBIO Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At REGENXBIO Inc.'s shareholder meeting held May 29, 2026, in the 2025-2026 proxy season, 179 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,502 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote on the compensation paid to the Company's executive employees. — REGENXBIO Inc.'s filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: REGENXBIO Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from REGENXBIO Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
REGENXBIO Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “REGENXBIO (RGNX) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/regenxbio-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.